D
DexCom, Inc. (DXCM)
NMS – Real Time Price. Currency in USD
62.25
-3.84 (-5.81%)
At close: Mar 27, 2026, 4:00 PM EDT
61.70
-0.55 (-0.88%)
After-hours: Mar 27, 2026, 7:35 PM EDT
Get all premium features to the best stock analysis tool
NMS – Real Time Price. Currency in USD
62.25
-3.84 (-5.81%)
At close: Mar 27, 2026, 4:00 PM EDT
61.70
-0.55 (-0.88%)
After-hours: Mar 27, 2026, 7:35 PM EDT
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
| Name | Position |
|---|---|
| Mr. Donald M. Abbey | Executive Vice President of Global Business Services, Regulatory, Medical & Clinical Affairs |
| Mr. Girish Naganathan | Executive VP & CTO |
| Mr. Jacob Steven Leach | President, CEO & Director |
| Mr. Jereme M. Sylvain CPA | Executive VP, CFO & Chief Accounting Officer |
| Mr. Jon Coleman | Executive VP & Chief Commercial Officer |
| Mr. Kevin Ronald Sayer | Executive Chairman of the Board |
| Mr. Matthew Dolan | Executive Vice President of Strategy & Corporate Development |
| Date | Type | Document |
|---|---|---|
| 2026-03-02 | 8-K | dxcm-20260227.htm |
| 2026-01-12 | 8-K | dxcm-20260107.htm |
| 2025-12-22 | 8-K | dxcm-20251219.htm |
| 2025-10-30 | 10-Q | dxcm-20250930.htm |
| 2025-10-27 | 8-K | dxcm-20251024.htm |
| 2025-09-16 | 8-K | dxcm-20250914.htm |
| 2025-07-30 | 8-K | dxcm-20250725.htm |
| 2025-05-29 | SD | dxcm2025formsd.htm |
| 2025-05-13 | 8-K | dxcm-20250509.htm |
| 2025-05-09 | 8-K | dxcm-20250508.htm |
| Mr. Michael Jon Brown |
| Executive VP & Chief Legal Officer |
| Mr. Sean Christensen | Vice President of Finance and Investor Relations |
| Ms. Sadie M. Stern | Executive VP & Chief Human Resources Officer |